Purchase Order HHSN268201800026A
Award Date 12/7/17
Potential Completion Date 12/31/20
Potential Value $804K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Bethesda, MD 20852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Human Genome Research Institute awarded a firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, to provide MiSeq and NovaSeq 600 sequencing services. The $110,226.52 contract has a completion date of June 4, 2024 and does not utilize any set-aside provisions. The contract was awarded on June 5, 2023 pursuant to a...
- This is a firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $770,306.04, was awarded to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract does not have a set-aside designation. Under this contract, Illumina will provide a range of goods and services to support genomic sequencing...
- This firm fixed-price purchase order contract, awarded by the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH), provides Illumina, Inc. with a NovaSeq X Plus sequencing system to support genomic research initiatives. The $999,999.00 contract has a completion date of September 19, 2024. Illumina is a leading manufacturer of genetic sequencing and analysis technologies, and has been awarded numerous federal contracts and grants to supply sequencing...
- This is a firm fixed-price delivery order awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical instruments. The contract, valued at $149,982.23, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services,...
- This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Human Genome Research Institute to Illumina, Inc., a manufacturer of gene sequencing instruments and reagents. The $148,651.94 firm fixed price delivery order is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as associated reagents, consumables, and support services. This contract does not have a set-aside...
- This federal contract award was made by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a for-profit organization and manufacturer of sequencing and genomic analysis solutions. The contract, valued at $112,216.00, is for the purchase of Illumina's sequencing systems, reagents, and other products to support genomic research and diagnostics. The contract is a firm fixed price purchase order with no set-aside designation....
- This is a firm fixed-price delivery order awarded by the National Human Genome Research Institute (NHGRI) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $498,777.14 contract is to provide Illumina sequencing systems, reagents, and services to support genomic sequencing and analysis for NHGRI's research and diagnostic needs. Illumina has been awarded multiple federal contracts and sub-grants by agencies such as the National...
- This is a firm fixed-price delivery order contract awarded by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health, to Illumina, Inc., a manufacturer of sequencing and genomic analysis products. The contract, valued at $100,213.37, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance...
- The Department of Health and Human Services' National Institutes of Health awarded a $4,570.01 firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and reagents, for the provision of Illumina MiSeq sequencing kits. The contract has no set-aside designation and was awarded on July 28, 2017, with a completion date of August 7, 2017. Illumina has a history of providing sequencing instruments, consumables, and services to support genomic...
- This is a federal contract award to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $149,627.88, was awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract is a delivery order and is a firm fixed-price arrangement, with no set-aside designation. Illumina has previously provided a range of sequencing systems, reagents,...